首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗癌药细胞色素P450 1B1抑制剂的研究进展
引用本文:张同,周金培,黄文龙.抗癌药细胞色素P450 1B1抑制剂的研究进展[J].药学进展,2005,29(5):197-202.
作者姓名:张同  周金培  黄文龙
作者单位:中国药科大学药化教研室,江苏,南京,210009
摘    要:介绍了有关人细胞色素P450 1B1(CYP1B1)抑制剂的研究概况。CYP1B1是一类在导致癌变的雌激素代谢和激活芳香烃化合物致癌性中起重要作用的酶,在正常组织中通常不表达而在许多肿瘤组织中表达活跃,同时对许多抗癌药物的代谢具有重要影响。这表明CYP1B1抑制剂有望成为又一类肿瘤治疗药物。

关 键 词:细胞色素P450  1B1  抑制剂  抗癌
文章编号:1001-5094(2005)05-0197-06
修稿时间:2004年11月22

Research on the CYP 1B1 Inhibitors as Anti-cancer Drugs
ZHANG Tong,ZHOU Jin-pei,HUANG Wen-long.Research on the CYP 1B1 Inhibitors as Anti-cancer Drugs[J].Progress in Pharmaceutical Sciences,2005,29(5):197-202.
Authors:ZHANG Tong  ZHOU Jin-pei  HUANG Wen-long
Institution:ZHANG Tong,ZHOU Jin-pei,HUANG Wen-long *
Abstract:The inhibitors of the human cytochrome P450 1B1 (CYP1B1) were summarized. CYP1B1 is a major enzyme in carcinogenic metabolism of estrogen and in the metabolic activation of procarcinogens of the polycyclic aromatic hydrocarbons (PAHs). It expresses in various human cancers at a high frequency,but not in normal tissues. CYP1B1 also affects the metabolism of various anticancer drugs. These findings suggest that inhibition of CYP1B1 may be a new oncological therapeutic strategy.
Keywords:Cytochrome P450 1B1  CYP 1B1 inhibitors  Anti-cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号